Covered recipient · General Payments record
PATRICIA M VUGUIN
Allopathic & Osteopathic Physicians Pediatrics Pediatric Endocrinology
General Payments · PY2019–2024
$3,000.24
- Reported across 43 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $633.14 | 24 |
| Education | $8.45 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $230.75 | 11 |
| BioMarin Pharmaceutical Inc. | $123.20 | 1 |
| Endo USA, Inc. | $81.73 | 4 |
| Takeda Pharmaceuticals U.S.A., Inc. | $47.95 | 2 |
| Endo Pharmaceuticals Inc. | $39.97 | 2 |
| GENZYME CORPORATION | $37.38 | 1 |
| Azurity Pharmaceuticals, Inc. | $34.35 | 2 |
| Pharming Healthcare, Inc. | $25.00 | 1 |
| Grifols USA, LLC | $21.26 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (25)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2019202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $8.45 | 02/20/2024 | Education | Undisputed | 01/23/2026 | 1106293760 | CMS |
| ABBVIE INC. | $28.96 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106293762 | CMS |
| ABBVIE INC. | $23.95 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106293764 | CMS |
| ABBVIE INC. | $27.12 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106293766 | CMS |
| ABBVIE INC. | $24.53 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106293768 | CMS |
| ABBVIE INC. | $17.06 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106293770 | CMS |
| ABBVIE INC. | $15.54 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106293772 | CMS |
| ABBVIE INC. | $23.96 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106293774 | CMS |
| ABBVIE INC. | $19.16 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106293776 | CMS |
| ABBVIE INC. | $20.77 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106293778 | CMS |
| ABBVIE INC. | $21.25 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106293780 | CMS |
| Azurity Pharmaceuticals, Inc. | $17.21 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134014013 | CMS |
| Azurity Pharmaceuticals, Inc. | $17.14 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134014015 | CMS |
| BioMarin Pharmaceutical Inc. | $123.20 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127060009 | CMS |
| Endo Pharmaceuticals Inc. | $17.30 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137018300 | CMS |
| Endo Pharmaceuticals Inc. | $22.67 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137018302 | CMS |
| Endo USA, Inc. | $23.83 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138589422 | CMS |
| Endo USA, Inc. | $20.64 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138589424 | CMS |
| Endo USA, Inc. | $15.96 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138589426 | CMS |
| Endo USA, Inc. | $21.30 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138589428 | CMS |
| GENZYME CORPORATION | $37.38 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139805174 | CMS |
| Grifols USA, LLC | $21.26 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124716890 | CMS |
| Pharming Healthcare, Inc. | $25.00 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132169892 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $20.52 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137693504 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $27.43 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137693506 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.